ArticleBMC neurology2026
Association between continuous metabolic syndrome score and incident dementia: a longitudinal study of middle-aged and older Chinese adults.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile metabolic syndrome (MetS) is a well-established driver of cognitive decline, conventional dichotomous diagnostic criteria fail to capture the cumulative and synergistic allostatic load of metabolic dysfunction. We investigated the longitudinal association between an age- and sex-standardized continuous MetS severity score and risk of incident dementia in a nationally Chinese cohort.
methodsThis prospective analysis utilized data from the China Health and Retirement Longitudinal Study. A continuous MetS score was calculated at baseline integrating waist circumference, triglycerides, high-density lipoprotein cholesterol, mean arterial pressure, and fasting blood glucose via validated linear models, and then quartiled (lowest quartile as reference). Incident dementia was ascertained during the Wave 4 follow-up using a rigorous, multidimensional diagnostic protocol. The dose-response relationship was evaluated using restricted cubic splines (RCS) and logistic regression.
resultsAmong 4,920 dementia-free participants at baseline, 667 (13.56%) developed dementia over the follow-up. RCS modeling revealed a significant, linear dose-response association between increasing MetS scores and dementia risk. Each 1-SD increment in the MetS score was independently associated with a 12% higher risk of dementia (OR = 1.12, 95% CI: 1.01-1.24). Participants in the highest quartile group faced a 48% increased risk compared to those in the lowest quartile (OR = 1.48, 95% CI: 1.07-2.04). This risk amplification was uniquely pronounced among non-obese individuals (BMI < 24 kg/m
conclusionsAn elevated continuous MetS score is a robust, independent predictor of incident dementia in middle-aged and older adults. Transitioning from binary criteria to a continuous MetS metric provides a nuanced, dose-dependent assessment of dementia risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.